Content about Biotechnology

November 9, 2010
Report: FDA’s Hamburg says creating biosimilars pathway likely to be complex

To express it in modern parlance, follow-on biologics will be a hot mess....

November 2, 2010
BIO, GPhA and Sandoz testify at FDA biosimilars hearing

The main lobbies for the biotechnology and generic drug industries, and a leading manufacturer of...

November 1, 2010
Amgen R&D chief testifies at FDA biosimilar hearing

Amgen's SVP research and development, Joe Miletich, urged members of a Food and Drug Administration...

November 1, 2010
PhRMA to testify at FDA hearing

The Food and Drug Administration should ensure patient access, safety and efficacy; create a transparent...

October 10, 2010
Reporters Notebook

Johnson & Johnson is set to buy the remaining portion of Dutch biotech company Crucell...

October 6, 2010
Spherix's Type 2 diabetes drug caused 'significant drop' in patients' HbA1c levels

Relatively healthy patients with Type 2 diabetes experienced a significant reduction in blood-sugar levels when...

October 4, 2010
HGS, Novartis halt further development of Zalbin

Human Genome Sciences and Novartis have decided not to further develop an investigative biologic treatment...

September 29, 2010
Teva receives complete response letter for Neutroval

The Food and Drug Administration declined to approve a Teva biosimilar, the generic drug maker...

September 28, 2010
Decision Resources: Crohn's disease drug market will increase 31% by 2019

The drug market for Crohn's disease treatments will see moderate growth over the next decade,...

September 28, 2010
Oncologists favor biosimilar adoption, Decision Resources finds

While biosimilars promise to provide therapies for a wide range of diseases, their biggest fans...

September 27, 2010
Endo boosts portfolio with Qualitest acquisition

Endo Pharmaceuticals will acquire generic drug maker Qualitest Pharmaceuticals for $1.2 billion, Endo said Tuesday....

September 26, 2010
Biosimilars’ future predicted to be as uncontroversial as generics

Biosimilars, biogenerics, follow-on biologics—whatever the designation one prefers for knockoffs of biotech drugs—they will soon...

September 26, 2010
Pfizer subsidiary to market authorized generics

The generics subsidiary of Pfizer is launching a new business focused on authorized generics. Greenstone...

September 26, 2010
Q&A: A dose of generic Meda-cine

Many generic drug companies have long marketed branded drugs on the side, but lately, some...

September 26, 2010
Senate, courts debate legality of patent settlement deals

For all its successes, the generic drug industry has had a lot to worry about...

September 8, 2010
Hi-Tech Pharmacal posts $3 million loss

Hi-Tech Pharmacal had $40.4 million in sales during its fiscal first quarter ended July 31,...

September 7, 2010
GSK inks deal with Lonza, announces CFO's exit

Swiss drug maker Lonza will help British drug maker GlaxoSmithKline manufacture five biotech drugs in...

August 29, 2010
MedImmune confirms second CRL from FDA for motavizumab

AstraZeneca's biologics unit has received a second complete response letter from the Food and Drug...

August 23, 2010
Sanofi-Aventis suing Sandoz to prevent generic blood thinner from reaching the market

French drug maker Sanofi-Aventis is suing to stop Sandoz’ generic version of its blood thinner...

August 19, 2010
BioMarin Pharmaceutical acquires ZyStor Therapeutics

BioMarin Pharmaceutical has acquired privately owned biotechnology company ZyStor Therapeutics for $22 million, BioMarin said....

August 15, 2010
Meda ventures into generic drugs

A lot of generic drug companies have conducted business in the branded drug market on...

August 12, 2010
Emergent acquires Trubion in near $100 million deal

Emergent BioSolutions will acquire Trubion Pharmaceuticals for $96.8 million upfront, under a deal the two...

August 2, 2010
Hospira reports Q2 sales, announces clinical trial for biosimilar

Hospira had net sales of $968 million and profits of $83.5 million in second quarter...

July 21, 2010
Forest, Merz announce Namenda patent settlements

Several generic drug makers have settled with Forest Labs and German drug maker Merz Pharma...

July 20, 2010
Decision Resources: Only half of payers support biosimilar substitution

Biosimilars may have cleared their biggest stretch of wilderness thanks to their inclusion in the...

© 2013 Drug Store News. All Rights Reserved.